Using AI Risk Estimates in Prostate Cancer Treatment Decisions - Urology Times
Daniel Spratt, MD, explains how he layers MMAI results onto NCCN risk groups and how he manages discordant results in both directions.
Read the original at Urology Times ↗
- Topics
- Healthcare
- Tracked via
- “AI Risks”
Same story, other outlets
- Benchmarking AI Risk Estimates in Prostate Cancer Against STAR-CAP | Urology Times Urology Times · Oct 10, 2026